Credit Suisse Asset Management has increased its investment product range with the launch of two fun...
Credit Suisse Asset Management has increased its investment product range with the launch of two funds - Global Health Care fund and European Convertible Bond fund.
Global Health Care will tap investors betting on the spin off opportunities of an ageing population, increasing longevity and the search for cures to illnesses. This say Credit Suisse in addition to health care industry consolidation and increasing use of technology creates an attractive longer-term investment proposition.
The type of companies it plans to invest are principally large to mid-cap companies in pharmaceuticals, medical technology, biotechnology and those providing equipment and services to hospitals and clinics.
Global Health Care fund manager Emil Doerig said: "We have witnessed an increasing appetite among both institutional and private investors for opportunities to invest in this sector, which has historically provided above average rates of return. However, many investors do not have access to the technological and sector expertise to invest confidently. The fund allows investors to benefit from our industry expertise."
The European Convertible Bond focuses on convertible fixed income securities from high quality issuers with investment going to companies with steady earnings within growth sectors with proven track records of delivery. Its fund manager Winifred Robbins said; "Convertibles offer investors an opportunity to benefit both from the upside potential of equities whilst also being able to benefit from some downside protections during periods of market weakness."
Two global vehicles
'Further plug advice gap'
Must appoint separate CEOs and boards
Advisers do come out well
Will report to Mark Till